Related Experiment Video
Updated: May 7, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Uric acid, hypertension, and cardiovascular and renal complications
Carmine Zoccali1, Francesca Mallamaci
1CNR National Research Council (Italy) Clinical Epidemiology and Physiopathology of Renal Disease and Hypertension Unit and Nephrology, Hypertension and Renal Transplantation unit, Ospedali Riuniti, Reggio Calabria, 89124, Italy, carmine.zoccali@tin.it.
Insights
High uric acid levels (hyperuricemia) may harm the heart and kidneys. However, more research is needed to confirm if lowering uric acid prevents cardiovascular and kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Diseases
Background:
- Hyperuricemia is linked to cardiovascular (CV) and kidney disease.
- Experimental and epidemiological studies suggest hyperuricemia may be detrimental to the CV system and kidneys.
Purpose of the Study:
- To evaluate the impact of hyperuricemia on cardiovascular and renal health.
- To assess the need for uric acid-lowering interventions in asymptomatic hyperuricemia.
Main Methods:
- Review of experimental studies in animal models and in vitro.
- Analysis of epidemiological studies.
- Assessment of existing clinical trial data.
Main Results:
- Experimental data suggest hyperuricemia can cause hypertension, endothelial dysfunction, vascular damage, and renal disease.
- Epidemiological studies support the hypothesis that hyperuricemia is harmful to the CV system and kidneys.
- Lack of well-powered trials investigating uric acid-lowering interventions for CV and renal outcomes.
Conclusions:
- Current evidence is insufficient to recommend uric acid-lowering drugs for asymptomatic hyperuricemia.
- Further high-quality clinical trials are necessary to determine the benefits of uric acid reduction.
Abstract:
Over the last decade, the biologic interference of uric acid with the cardiovascular (CV) system and the kidney has been intensively investigated, and several experimental studies in animal models and in vitro documented that hyperuricemia may trigger hypertension and incite endothelial dysfunction, vascular damage and renal disease. A substantial proportion of epidemiological studies are compatible with the hypothesis that hyperuricemia may be noxious to the CV system and the kidney as well. However, there are still no well-powered trials testing whether uric acid-lowering interventions may reduce BP or attenuate the risk for adverse CV and renal outcomes. Evidence still remains largely insufficient to recommend changes in the current policy of not prescribing uric acid-lowering drugs to individuals with asymptomatic hyperuricemia.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Antihypertensive Drugs: Action of Diuretics
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Hemodialysis II: Procedure and Complications
Urinary Tract Calculi I: Introduction
Diabetic Nephropathy